NCT06534216Active, not recruiting
Role of Intestinal Ultrasound in Treat to Target Strategy in the Management of Inflammatory Bowel Disease : the IUS-TTT Study
Source: ClinicalTrials.gov · Last updated 17 Jul 2025
Brief summary (registry, in English)
This study aims to evaluate the role of bedside Intestinal Ultrasound (IUS) as a cost-effective, non-invasive, and well-tolerated procedure within the Treat-to-Target strategy for managing Inflammatory Bowel Disease (IBD). Despite its growing use, therapeutic targets for IUS-guided treatment remain inadequately defined. The study will investigate the feasibility of IUS in monitoring transmural response and remission, and its potential to predict clinical and biochemical responses at 3 months, as well as mucosal healing at 6 and 12 months. By incorporating IUS into routine clinical care, we aim to enhance disease management and optimize therapeutic outcomes for patients with ulcerative colitis and Crohn's disease.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 30 Jul 2024
- Start date
- 5 Apr 2024
- Primary completion date
- 4 Mar 2026
- Lead sponsor
- Asian Institute of Gastroenterology, India
- Diseases
- Crohn's disease, Ulcerative colitis
- NCT number
- NCT06534216
What you commit to
- Study type: Observational
- Planned participants: 100
- From 5 Apr 2024 to the primary completion date, 4 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Intestinal ultrasound for assessment of response to therapy
Other illness
- Intestinal ultrasound for clinically asymptomatic disease
Age
- Age \< 18 years
Other
- Pregnancy and lactating mothers
Who the study is looking for
- Adults over the age of 18 years.
- Active Crohn's disease, defined as a Simple Endoscopic Score for Crohn's Disease of 3 or higher.
- Active ulcerative colitis, defined as an Ulcerative Colitis Endoscopic Index of Severity of 2 or higher.
Age in the registry: 18 years to 70 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Asian Institute Of Gastroenterology Coordinator of this site? Confirm its status | Hyderabad | India | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.